VANDA PHARMACEUTICALS INC. Public Float
VANDA PHARMACEUTICALS INC. (VNDA) had Public Float of $268.70 million as of 2025-06-30, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-12
- 2025-06-30: Entity Public Float $268.70M.
- 2024-06-30: Entity Public Float $319.50M.
- 2023-06-30: Entity Public Float $368.70M.
- 2022-06-30: Entity Public Float $601.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $268.70M 10-K · filed 2026-02-12 |
| 2024-06-30 | $319.50M 10-K · filed 2025-02-14 |
| 2023-06-30 | $368.70M 10-K · filed 2024-02-08 |
| 2022-06-30 | $601.30M 10-K · filed 2023-02-09 |
| 2021-06-30 | $1.17B 10-K · filed 2022-02-24 |
| 2020-06-30 | $609.80M 10-K · filed 2021-02-11 |
| 2019-06-30 | $731.20M 10-K · filed 2020-02-26 |
| 2018-06-30 | $974.30M 10-K · filed 2019-02-19 |
| 2017-06-30 | $715.20M 10-K · filed 2018-02-15 |
| 2016-06-30 | $473.60M 10-K · filed 2017-02-17 |
| 2015-06-30 | $525.70M 10-K · filed 2016-02-12 |
| 2014-06-30 | $380.60M 10-K · filed 2015-03-13 |
| 2013-06-28 | $194.00M 10-K · filed 2014-02-25 |
| 2012-06-29 | $106.20M 10-K · filed 2013-02-26 |
| 2011-06-30 | $197.78M 10-K · filed 2012-03-09 |
| 2010-06-30 | $181.89M 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |